Ernesto S. Nakayasu

Jan 19, 2025 | nature.com | Lisa M. Bramer |Ernesto S. Nakayasu |Michael J MacCoss |Thomas Metz

AbstractThe deployment of liquid chromatography-mass spectrometry-based plasma proteomics experiments in a large cohort is sparse, leading to a lack of data available for benchmarking, method development or validation. Comprised of 6,426 plasma analyses, The Environmental Determinants of Diabetes in the Young (TEDDY) proteomics validation study constitutes one of the largest targeted proteomics experiments in the literature to date.

Mar 1, 2024 | nature.com | Sanjay Jain |Liming Pei |Jeffrey M. Spraggins |Joana Gonçalves |John Hickey |Neil L. Kelleher | +9 more

Correction to: Nature Cell Biology https://doi.org/10.1038/s41556-023-01194-w. Published online 19 July 2023. In the version of this article originally published, the name of Tianyang Xu was misspelled as Tiangyang Xu. The name has been corrected in the HTML and PDF versions of the article. About this articleJain, S., Pei, L., Spraggins, J.M. et al. Author Correction: Advances and prospects for the Human BioMolecular Atlas Program (HuBMAP). Nat Cell Biol (2024).

Jul 19, 2023 | nature.com | Sanjay Jain |Liming Pei |Jeffrey M. Spraggins |Joana Gonçalves |John Hickey |Neil L. Kelleher | +9 more

Data types, organs and technologiesSince the second quarter of 2023, HuBMAP datasets using 18 different analytical technologies or assay types have been publicly available (Figs. 1a and 2). These encompass 1,672 publicly available datasets from regions with no histopathologic abnormality from 14 organs across 180 donors. Protocols were optimized to minimize the ischaemia time of healthy donors. All published data are freely available via the HuBMAP portal (https://portal.hubmapconsortium.org).